Potential protective effect of highly bioavailable curcumin on an oxidative stress model induced by microinjection of sodium nitroprusside in mice brain

Food and Function

Volumn 5, Issue 5, 2014, Pages 984-989

  Nazari, Qand Agha ^a   Takada Takatori, Yuki ^b   Hashimoto, Tadashi ^c   Imaizumi, Atsushi ^c   Izumi, Yasuhiko ^a   Akaike, Akinori ^a,d   Kume, Toshiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^c Theravalues Corporation   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BRAIN; COMMINUTION; MAMMALS;

ANTI-INFLAMMATORIES; ANTIOXIDANT EFFECT; ORAL ADMINISTRATION; ORAL BIOAVAILABILITIES; OXIDATIVE DAMAGE; PHARMACOLOGICAL ACTIVITY; PROTECTIVE EFFECTS; SODIUM NITROPRUSSIDE;

SODIUM;

CURCUMIN; NEUROPROTECTIVE AGENT; NITROPRUSSIDE SODIUM;

ANIMAL; BIOAVAILABILITY; BRAIN; DRUG EFFECTS; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

ANIMALS; BIOLOGICAL AVAILABILITY; BRAIN; CURCUMIN; HUMANS; MALE; MICE; MICE, INBRED ICR; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; NITROPRUSSIDE; OXIDATIVE STRESS;

EID: 84899505008     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c4fo00009a     Document Type: Article

References (39)

1. A. C. Cristóvão S. Guhathakurta E. Bok G. Je S. D. Yoo D. H. Choi Y. S. Kim NADPH Oxidase 1 Mediates α-Synucleinopathy in Parkinson's Disease J. Neurosci. 2012 32 14465 14477
2. P. Sompol W. Ittarat J. Tangpong Y. Chen I. Doubinskaia I. Batinic-Haberle H. M. Abdul D. A. Butterfield D. K. St Clair A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury Neuroscience 2008 22 120 130
3. T. H. Sanderson C. A. Reynolds R. Kumar K. Przyklenk M. Hüttemann Molecular Mechanisms of Ischemia-Reperfusion Injury in Brain: Pivotal Role of the Mitochondrial Membrane Potential in Reactive Oxygen Species Generation Mol. Neurobiol. 2013 47 9 23
4. X. D. Chao Y. H. Ma P. Luo L. Cao W. B. La B. C. Zhao F. Han W. Liu W. D. Ning N. Su L. Zhang J. Zhu Z. Fei Y. Qu Up-regulation of Heme oxygenase-1 attenuates brain damage after cerebral ischemia via simultaneous inhibition of superoxide production and preservation of NO bioavailability Exp. Neurol. 2013 239 163 169
5. T. M. Andriessen B. Jacobs P. E. Vos Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury J. Cell. Mol. Med. 2010 14 2381 2392
6. A. Durukan T. Tatlisumak Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia Pharmacol. Biochem. Behav. 2007 87 179 197
7. K. Cui X. Luo K. Xu M. R. Ven Murthy Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants Prog. Neuropsychopharmacol. Biol Psychiatry. 2004 28 771 799
8. B. Uttara A. V.Singh P. Zamboni R. T. Mahajan Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options Curr. Neuropharmacol. 2009 7 65 74
9. M. Valko D. Leibfritz J. Moncol M. T. Cronin M. Mazur J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int. J. Biochem. Cell Biol. 2007 39 44 84
10. A. T. Diplock J. L. Charleux G. Crozier-Willi F. J. Kok C. Rice-Evans M. Roberfroid W. Stahl J. Viña-Ribes Functional food science and defence against reactive oxidative species Br. J. Nutr. 1998 80 77 112
11. A. Goel A. B. Kunnumakkara B. B. Aggarwal Curcumin as ''Curecumin'': From kitchen to clinic Biochem. Pharmacol. 2008 75 787 809
12. A. Shehzad F. Wahid Y. S. Lee Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials Arch. Pharm. 2010 343 489 499
13. N. P. Wang Z. F. Wang S. Tootle T. Philip Z. Q. Zhao Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction Br. J. Pharmacol. 2012 167 1550 1562
14. J. S. Jurenka Anti-inflammatory Properties of Curcumin, a Major Constituent of Curcuma longa: A Review of Preclinical and Clinical Research Altern. Med. Rev. 2009 14 141 153
15. G. M. Cole B. Teter S. A. Frautschy Neuroprotective Effects of Curcumin Adv. Exp. Med. Biol. 2007 595 197 212
16. R. Barreto S. Kawakita J. Tsuchiya E. Minelli K. Pavasuthipaisit A. Helmy F. Marotta Metal-induced oxidative damage in cultured hepatocytes and hepatic lysosomal fraction: beneficial effect of a curcumin/absinthium compound Chin. J. Dig. Dis. 2005 6 3 6
17. H. C. Huang C. J. Lin W. J. Liu R. R. Jiang Z. F. Jiang Dual effects of curcumin on neuronal oxidative stress in the presence of Cu(ii) Food Chem. Toxicol. 2011 49 1578 1583
18. S. Rong Y. Zhao W. Bao X. Xiao D. Wang A. K. Nussler H. Yan P. Yao L. Liu Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity Phytomedicine 2012 19 545 550
19. H. H. Tønnesen M. Másson T. Loftsson Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability Int. J. Pharm. 2002 244 127 135
20. R. A. Sharma A. J. Gescher W. P. Steward Curcumin: the story so far Eur. J. Cancer 2005 41 1955 1968
21. H. Sasaki Y. Sunagawa K. Takahashi A. Imaizumi H. Fukuda T. Hashimoto H. Wada Y. Katanasaka H. Kakeya M. Fujita K. Hasegawa T. Morimoto Innovative Preparation of Curcumin for Improved Oral Bioavailability Biol. Pharm. Bull. 2011 34 660 665
22. M. Kanai A. Imaizumi Y. Otsuka H. Sasaki M. Hashiguchi K. Tsujiko S. Matsumoto H. Ishiguro T. Chiba Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Cancer. Chemother. Pharmacol. 2012 69 65 70
23. Q. A. Nazari K. Mizuno T. Kume Y. Takada-Takatori Y. Izumi A. Akaike In Vivo Brain Oxidative Stress Model Induced by Microinjection of Sodium Nitroprusside in Mice J. Pharmacol. Sci. 2012 120 105 111
24. G. Rozas E. López-Martín M. J. Guerra J. L. Labandeira-García The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism J. Neurosci. Methods 1998 83 165 175
25. F. Richter M. Hamann A. Richter Chronic Rotenone Treatment Induces Behavioral Effects but No Pathological Signs of Parkinsonism in Mice J. Neurosci. Res. 2007 85 681 691
26. X. Y. Qin Y. Cheng L. C. Yu Potential protection of curcumin against intracellular amyloid β-induced toxicity in cultured rat prefrontal cortical neurons Neurosci. Lett. 2010 480 21 24
27. H. Hatcher R. Planalp J. Cho F. M. Torti S. V. Torti Curcumin: from ancient medicine to current clinical trials Cell. Mol. Life Sci. 2008 65 1631 1652
28. I. Carmona-Ramírez A. Santamaría J. C. Tobón-Velasco M. Orozco-Ibarra I. G. González-Herrera J. Pedraza-Chaverrí P. D. Maldonado Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity J. Nutr. Biochem. 2013 24 14 24
29. G. Khuwaja M. M. Khan T. Ishrat A. Ahmad S. S. Raza M. Ashafaq H. Javed M. B. Khan A. Khan K. Vaibhav M. M. Safhi F. Islam Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical and immunohistochemical studies Brain Res. 2011 1368 254 263
30. M. H. Pan T. M. Huang J. K. Lin Biotransformation of Curcumin through Reduction and Glucuronidation in Mice Drug. Metab. Dispos. 1999 27 486 494
31. C. D. Lao D. Normolle D. D. Heath S. I. Murray J. M. Bailey M. E. Boggs J. Crowell C. L. Rock D. E. Brenner Dose escalation of a curcuminoid formulation BMC Complementary Altern. Med. 2006 6 10
32. X. Xie Q. Tao Y. Zou F. Zhang M. Guo Y. Wang H. Wang Q. Zhou S. Yu PLGA Nanoparticles Improve the Oral Bioavailability of Curcumin in Rats: Characterizations and Mechanisms J. Agric. Food Chem. 2011 59 9280 9289
33. L. Zhongfa M. Chiu J. Wang W. Chen W. Yen P. Fan-Havard L. D. Yee L. D. K. K. Chan Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice Cancer. Chemother. Pharmacol 2012 69 679 689
34. C. Schiborr G. P. Eckert G. Rimbach J. Frank A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection Anal. Bioanal. Chem. 2010 397 1917 1925
35. Y. M. Tsai C. F. Chien L. C. Lin T. H. Tsai Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration Int. J. Pharm. 2011 416 331 338
36. D. Suresh K. Srinivasan Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats Indian. J. Med. Res. 2010 131 682 691
37. R. B. Mythri M. M. Bharath Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease Curr. Pharm. Des. 2012 18 91 99
38. D. Chin P. Huebbe K. Pallauf G. Rimbach Neuroprotective properties of curcumin in Alzheimer's disease-merits and limitations Curr. Med. Chem. 2013 20 3955 3985
39. T. Esatbeyoglu P. Huebbe I. M. Ernst D. Chin A. E. Wagner G. Rimbach Curcumin-from molecule to biological function Angew. Chem., Int. Ed. Engl. 2012 51 5308 5332